[-] Show simple item record

dc.contributor.authorBrooke, Shannoneng
dc.contributor.authorWhitworth, James D.eng
dc.contributor.authorCalabretta, Nancyeng
dc.date.issued2009eng
dc.description.abstractMonitor the patient and treat her with intrapartum chemoprophylaxis based on identified risk factors, unless a rapid, highly sensitive (greater than or equal to 85%) polymerase chain reaction (PCR) test is immediately available to evaluate for group B Streptococcus (GBS) (strength of recommendation: B, inconsistent or limited quality evidence).eng
dc.identifier.urihttp://hdl.handle.net/10355/3879eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2009 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 58, no. 01 (January 2009): 42-43.eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectneo-natal bacteremiaeng
dc.subjectantibiotic prophylaxiseng
dc.subjectchlorhexidineeng
dc.subject.lcshStreptococcus agalactiaeeng
dc.subject.lcshCommunicable diseases in pregnancy -- Treatmenteng
dc.subject.lcshPregnancy -- Complicationseng
dc.subject.lcshChlorhexidine -- Effectivenesseng
dc.titleHow best to manage the patient in term labor whose group B strep status is unknown?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record